January 30, 2015 1:29 AM ET


Company Overview of Medicago Inc.

Executive Profile

Myron M. Levine M.D., D.t.p.h

Former Member of Scientific Advisory Board, VBI Vaccines Inc
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Myron M. Levine, Mike, M.D, DTPH is a Professor of Medicine, pediatrics, epidemiology and preventive medicine and microbiology and immunology at the University of Maryland's School of Medicine. Dr. Levine Co-founded and serves as Director of the University of Maryland School of Medicine's Center for Vaccine Development (CVD). Dr. Levine served the University of Maryland in many other capacities including Head of the Division of Infectious Diseases and Tropical Medicine ...

Corporate Headquarters

1020 Route de l'Église
Quebec, Quebec G1V 3V9


Phone: 418-658-9393
Fax: 418-658-6699

Board Members Memberships

Former Director and Member of Nominating & Governance Committee


Virginia Commonwealth University's School of Medicine
Unknown/Other Education 1974
London School Of Hygiene And Tropical Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Medicago Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.